Press Releases

Altasciences have been chosen by Steel Therapeutics, Inc. for their pivotal toxicology study for Fizurex™, a novel compounded topical wipe. The study is currently underway at our preclinical facility.

Altasciences is proud to announce that it has received a sustainability Gold Medal from EcoVadis, placing the contract research organization (CRO) in the 96th percentile and among the top 5% of companies evaluated globally.

Altasciences is partnering with VoxCell BioInnovation, a leader in 3D bioprinting and human-like tissue modeling, to enhance preclinical research and accelerate the path from discovery to clinical trials.

Altasciences is proud to announce they have been awarded a 2025 CDMO Leadership Award in the Small Molecule Dosage Form–North America category.

Altasciences is proud to have supported Metsera, Inc., a clinical stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, on its nonclinical and early-stage clinical trials.

Altasciences is committed to providing world-class bioanalytical services in support of the preclinical and clinical studies conducted at our cutting-edge facilities, as well as extensive standalone solutions to meet your diverse needs. Our flexible bioanalytical services from discovery to Phase IV empower our clients across every phase of research.

Altasciences is proud to announce that Dr. Beatrice Setnik, PhD, has been honored as a PharmaVoice 100 winner.